These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27480298)

  • 1. [A preliminary analysis on potentially targeted genes of induced chemotherapy in supraglottic laryngeal squamous cell carcinoma].
    Shi Q; Lian M; Fang JG; Liu HG; Meng LZ; Ma HZ; Feng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):504-10. PubMed ID: 27480298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo gene expression profiling for chemosensitivity to docetaxel-cisplatin-5-FU (TPF) triplet regimen in laryngeal squamous cell carcinoma and the effect of TPF treatment on related gene expression in vitro.
    Lian M; Shi Q; Fang J; Feng L; Ma H; Wang H; Zhang L; Wang H; Ma Z; Liu H
    Acta Otolaryngol; 2017 Jul; 137(7):765-772. PubMed ID: 28125325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis for potential targeting genes of TPF regimen induction chemotherapy in hypopharyngeal squamous cell carcinoma].
    Yang YF; Fang JG; Zhong Q; Wang R; Feng L; Hou LZ; Ma HZ; Shi Q; Lian M; He SZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 55(2):125-132. PubMed ID: 32074750
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.
    Bradford CR; Zhu S; Wolf GT; Poore J; Fisher SG; Beals T; McClatchey KD; Carey TE
    Otolaryngol Head Neck Surg; 1995 Oct; 113(4):408-12. PubMed ID: 7567013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of induction chemo-sensitivity genes of laryngeal squamous cell carcinoma and their clinical utilization.
    Li L; Wang R; He S; Shen X; Kong F; Li S; Zhao H; Lian M; Fang J
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2773-2781. PubMed ID: 30267217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A preliminary study on genome-wide expression profiling of laryngeal squamous cell carcinoma].
    Wang R; Ma H; Lian M; Yang F; Wang H; Feng L; Fang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 49(3):232-5. PubMed ID: 24820496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of molecular markers of induced chemotherapy in supraglottic laryngeal squamouscell carcinoma.
    Yang G; Fang J; Shi Q; Wang R; Lian M; Ma H; Feng L; Shen X; Wang Y
    World J Otorhinolaryngol Head Neck Surg; 2020 Mar; 6(1):34-40. PubMed ID: 32426701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.
    Shen LY; Wang H; Dong B; Yan WP; Lin Y; Shi Q; Chen KN
    Oncotarget; 2016 Jan; 7(4):4531-41. PubMed ID: 26673820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of concurrent chemoradiation in laryngeal preservation for supraglottic cancer.
    Yoon TM; Lee JK; Cho JS; Lim SC; Chung WK
    J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):142-9. PubMed ID: 20211100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinoma.
    Gregg CM; Beals TE; McClatchy KM; Fisher SG; Wolf GT
    Otolaryngol Head Neck Surg; 1993 Jun; 108(6):731-7. PubMed ID: 8516011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
    Pointreau Y; Garaud P; Chapet S; Sire C; Tuchais C; Tortochaux J; Faivre S; Guerrif S; Alfonsi M; Calais G
    J Natl Cancer Inst; 2009 Apr; 101(7):498-506. PubMed ID: 19318632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of supraglottic carcinoma: PTEN and thrombospondin 2 are associated with inhibition of lymphatic metastasis.
    Bai W; Wang L; Ji W; Gao H
    Acta Otolaryngol; 2009 May; 129(5):569-74. PubMed ID: 18720079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
    Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
    J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Wang J; Fan J; Gao W; Wu Y; Zhao Q; Chen B; Ding Y; Wen S; Nan X; Wang B
    Stem Cells Dev; 2020 Jun; 29(12):774-785. PubMed ID: 32178572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
    Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
    Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of downregulation of HDAC6 expression on cell cycle, proliferation and migration of laryngeal squamous cell carcinoma].
    Yuan LL; Wang F; Li SL; Lou WH; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):430-5. PubMed ID: 22967444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
    Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
    Nakashima S; Natsugoe S; Matsumoto M; Kijima F; Takebayashi Y; Okumura H; Shimada M; Nakano S; Kusano C; Baba M; Takao S; Aikou T
    Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.
    Mesía R; Vázquez S; Grau JJ; García-Sáenz JA; Lozano A; García C; Carles J; Irigoyen A; Mañós M; García-Paredes B; del Barco E; Taberna M; Escobar Y; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):289-96. PubMed ID: 26675064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.